Carol Prives

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Psychometric Properties

Top Venues

Molecular cancer research : MCR

Molecular and cellular biology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Gizem Efe, Anil K Rustgi, Carol Prives
p53 at the crossroads of tumor immunity. Nature cancer 5 (7) (2024)
Ana Maria Low-Calle, Hana Ghoneima, Nicholas Ortega, Adriana M Cuibus, Chen Katz, Carol Prives, Ron Prywes
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and cellular biology 44 (1) (2024)
Kausik Regunath, Vitalay Fomin, Zhaoqi Liu, Pingzhang Wang, Mainul Hoque, Bin Tian, Raúl Rabadán, Carol Prives
Systematic Characterization of p53-Regulated Long Noncoding RNAs across Human Cancers Reveals Remarkable Heterogeneity among Different Tumor Types. Molecular cancer research : MCR 22 (6) (2024)
Ana Maria Low-Calle, Hana Ghoneima, Nicholas Ortega, Adriana M Cuibus, Chen Katz, Carol Prives, Ron Prywes
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and cellular biology 44 (1) (2024)
Ana Maria Low-Calle, Hana Ghoneima, Nicholas Ortega, Adriana M Cuibus, Chen Katz, Carol Prives, Ron Prywes
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and cellular biology 44 (1) (2024)
Kausik Regunath, Vitalay Fomin, Zhaoqi Liu, Pingzhang Wang, Mainul Hoque, Bin Tian, Raúl Rabadán, Carol Prives
Systematic Characterization of p53-Regulated Long Noncoding RNAs across Human Cancers Reveals Remarkable Heterogeneity among Different Tumor Types. Molecular cancer research : MCR 22 (6) (2024)
Ana Maria Low-Calle, Hana Ghoneima, Nicholas Ortega, Adriana M Cuibus, Chen Katz, Carol Prives, Ron Prywes
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and cellular biology 44 (1) (2024)
Kausik Regunath, Vitalay Fomin, Pingzhang Wang, Zhaoqi Liu, Mainul Hoque, Bin Tian, Raúl Rabadán, Carol Prives
Systematic characterization of p53-regulated long non-coding RNAs across human cancers reveals remarkable heterogeneity among different tumor types. Molecular cancer research : MCR (2024)
Kausik Regunath, Vitalay Fomin, Zhaoqi Liu, Pingzhang Wang, Mainul Hoque, Bin Tian, Raúl Rabadán, Carol Prives
Systematic Characterization of p53-Regulated Long Noncoding RNAs across Human Cancers Reveals Remarkable Heterogeneity among Different Tumor Types. Molecular cancer research : MCR 22 (6) (2024)
Ana Maria Low-Calle, Hana Ghoneima, Nicholas Ortega, Adriana M Cuibus, Chen Katz, Carol Prives, Ron Prywes
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and cellular biology 44 (1) (2024)
Kausik Regunath, Vitalay Fomin, Zhaoqi Liu, Pingzhang Wang, Mainul Hoque, Bin Tian, Raúl Rabadán, Carol Prives
Systematic Characterization of p53-Regulated Long Noncoding RNAs across Human Cancers Reveals Remarkable Heterogeneity among Different Tumor Types. Molecular cancer research : MCR 22 (6) (2024)
Kausik Regunath, Vitalay Fomin, Pingzhang Wang, Zhaoqi Liu, Mainul Hoque, Bin Tian, Raúl Rabadán, Carol Prives
Systematic characterization of p53-regulated long non-coding RNAs across human cancers reveals remarkable heterogeneity among different tumor types. Molecular cancer research : MCR (2024)
Kausik Regunath, Vitalay Fomin, Pingzhang Wang, Zhaoqi Liu, Mainul Hoque, Bin Tian, Raúl Rabadán, Carol Prives
Systematic characterization of p53-regulated long non-coding RNAs across human cancers reveals remarkable heterogeneity among different tumor types. Molecular cancer research : MCR (2024)
Ana Maria Low-Calle, Hana Ghoneima, Nicholas Ortega, Adriana M Cuibus, Chen Katz, Carol Prives, Ron Prywes
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and cellular biology 44 (1) (2024)
Gizem Efe, Anil K Rustgi, Carol Prives
p53 at the crossroads of tumor immunity. Nature cancer (2024)
Ana Maria Low-Calle, Hana Ghoneima, Nicholas Ortega, Adriana M Cuibus, Chen Katz, Carol Prives, Ron Prywes
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63. Molecular and cellular biology (2024)
Gizem Efe, Karen J Dunbar, Kensuke Sugiura, Katherine Cunningham, Saul Carcamo, Spyros Karaiskos, Qiaosi Tang, Ricardo Cruz-Acuna, Lois Resnick-Silverman, Jessica Peura, Andrew O M Wilkie, Dan Hasson, Andres J Klein-Szanto, Alison M Taylor, James J Manfredi, Carol Prives, Anil K Rustgi
p53 gain-of-function mutation induces metastasis via Brd4-dependent Csf-1 expression. Cancer discovery (2023)
Joshua H Choe, Tatsuya Kawase, An Xu, Asja Guzman, Aleksandar Z Obradovic, Ana Maria Low-Calle, Bita Alaghebandan, Ananya Raghavan, Kaitlin Long, Paul M Hwang, Joshua D Schiffman, Yan Zhu, Ruiying Zhao, Dung-Fang Lee, Chen Katz, Carol Prives
Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death. Cancer discovery (2023)
Sawako Suzuki, Divya Venkatesh, Hiroaki Kanda, Akitoshi Nakayama, Hiroyuki Hosokawa, Eunyoung Lee, Takashi Miki, Brent R Stockwell, Koutaro Yokote, Tomoaki Tanaka, Carol Prives
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma. Cancer research 82 (18) (2022)